Savant Capital’s Wave Life Sciences WVE Stock Holding History
Bought
Maintained
Sold
Other funds holding WVE
6CM
Savant Capital's WVE Position: Q3 2026 in Review
Savant Capital reduced its Wave Life Sciences (WVE) stake by 20% in Q3 2026, selling an estimated $54.1K and leaving 41,987 shares worth $155K. The position accounts for ﹤0.01% of the portfolio, ranked #2251.
Savant Capital first reported a position in WVE in Q4 2025 and has held it in 4 quarters since. The position peaked at $327K in Q2 2026. 211 funds tracked by Wall St. Rank hold WVE as of Q3 2026.
- Savant Capital held 41,987 shares of Wave Life Sciences worth $155K as of Q3 2026.
- Savant Capital sold 10,288 Wave Life Sciences shares in Q3 2026, an estimated $54.1K.
- Wave Life Sciences made up ﹤0.01% of Savant Capital's portfolio in Q3 2026, its #2251 holding.
- Savant Capital first reported a position in Wave Life Sciences in Q4 2025 and has held it in 4 quarters since.
- Savant Capital's Wave Life Sciences position peaked at $327K in Q2 2026.
- 211 funds tracked by Wall St. Rank held Wave Life Sciences as of Q3 2026.
Based on Savant Capital's 13F filing for Q3 2026, filed 6 Nov 2026.